Howard A. Burris III, MD serves as the Director of Drug Development at Sarah Cannon Cancer Center and is an associate at Tennessee Oncology, PLLC, both located in Nashville, Tennessee.

William T. McGivney, PhD is Chief Executive Officer of the National Comprehensive Cancer Network (NCCN). At the NCCN, Dr. McGivney is responsible for the development of NCCN strategies and programs aimed at improving the quality of cancer care available to patients in need.

Chad A. Mirkin, PhD, Professor, Department of Chemistry. Director, International Institute for Nanotechnology at Northwestern University. Dr. Chad A. Mirkin's research focuses on developing methods for controlling the architecture of molecules and materials on the 1-100 nm length scale and utilizing such structures in the development of analytical tools that can be used in the areas of chemical and biological sensing, lithography, catalysis and optics.